Provided by Tiger Fintech (Singapore) Pte. Ltd.

Third Harmonic Bio, Inc.

5.16
+0.03000.58%
Post-market: 5.160.00000.00%16:07 EDT
Volume:525.91K
Turnover:2.70M
Market Cap:232.74M
PE:-4.74
High:5.17
Open:5.13
Low:5.11
Close:5.13
Loading ...

Company Profile

Company Name:
Third Harmonic Bio, Inc.
Exchange:
NASDAQ
Establishment Date:
2019
Employees:
53
Office Location:
1700 Montgomery Street,Suite 210,San Francisco,California,United States
Zip Code:
94111
Fax:
- -
Introduction:
Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.

Directors

Name
Position
Mark Iwicki
Chairman of the Board, Director
Natalie Holles
Chief Executive Officer and Director
David P. Bonita
Director
H. Martin Seidel
Director
Michael Gladstone
Director
Rob Perez
Director
Shao Lee Lin
Director
Thomas M. Soloway
Director

Shareholders

Name
Position
Natalie Holles
Chief Executive Officer and Director
Robert Ho
Chief Financial Officer
Adrian S. Ray
Chief Scientific Officer
Edward R. Conner
Chief Medical Officer
Julie Person
Chief Administrative Officer